Brain tumor (BT) is a rapid growth of brain cells. If the BT is not identified and treated in the first stage, it could cause death. Despite several methods and efforts being developed for segmenting and identifying BT, the detection of BT is complicated due to the distinct position of the tumor and its size. To solve such issues, this paper proposes the Conditional Autoregressive Value-at-Risk_Xception Maxout-Network (Caviar_XM-Net) for BT detection utilizing magnetic resonance imaging (MRI) images. The input MRI image gathered from the dataset is denoised using the adaptive bilateral filter (ABF), and tumor region segmentation is done using BFC-MRFNet-RVSeg. Here, the segmentation is done by the Bayesian fuzzy clustering (BFC) and multi-branch residual fusion network (MRF-Net) separately. Subsequently, outputs from both segmentation techniques are combined using the RV coefficient. Image augmentation is performed to boost the quantity of images in the training process. Afterwards, feature extraction is done, where features, like local optimal oriented pattern (LOOP), convolutional neural network (CNN) features, median binary pattern (MBP) with statistical features, and local Gabor XOR pattern (LGXP), are extracted. Lastly, BT detection is carried out by employing Caviar_XM-Net, which is acquired by the assimilation of the Xception model and deep Maxout network (DMN) with the CAViaR approach. Furthermore, the effectiveness of Caviar_XM-Net is examined using the parameters, namely sensitivity, accuracy, specificity, precision, and F1-score, and the corresponding values of 91.59%, 91.36%, 90.83%, 90.99%, and 91.29% are attained. Hence, the Caviar_XM-Net performs better than the traditional methods with high efficiency.

Identifying amyloid-beta (Aβ)-positive patients is essential for Alzheimer's disease (AD) clinical trials and disease-modifying treatments but currently requires PET or cerebrospinal fluid sampling. Previous MRI-based deep learning models, using only T1-weighted (T1w) images, have shown moderate performance. Multi-contrast MRI and PET-based quantitative Aβ deposition were retrospectively obtained from three public datasets: ADNI, OASIS3, and A4. Aβ positivity was defined using each dataset's recommended centiloid threshold. Two EfficientNet models were trained to predict amyloid positivity: one using only T1w images and another incorporating both T1w and T2-FLAIR. Model performance was assessed using an internal held-out test set, evaluating AUC, accuracy, sensitivity, and specificity. External validation was conducted using an independent cohort from Stanford Alzheimer's Disease Research Center. DeLong's and McNemar's tests were used to compare AUC and accuracy, respectively. A total of 4,056 exams (mean [SD] age: 71.6 [6.3] years; 55% female; 55% amyloid-positive) were used for network development, and 149 exams were used for external testing (mean [SD] age: 72.1 [9.6] years; 58% female; 56% amyloid-positive). The multi-contrast model outperformed the single-modality model in the internal held-out test set (AUC: 0.67, 95% CI: 0.65-0.70, <i>P</i> < 0.001; accuracy: 0.63, 95% CI: 0.62-0.65, <i>P</i> < 0.001) compared to the T1w-only model (AUC: 0.61; accuracy: 0.59). Among cognitive subgroups, the highest performance (AUC: 0.71) was observed in mild cognitive impairment. The multi-contrast model also demonstrated consistent performance in the external test set (AUC: 0.65, 95% CI: 0.60-0.71, <i>P</i> = 0.014; accuracy: 0.62, 95% CI: 0.58- 0.65, <i>P</i> < 0.001). The use of multi-contrast MRI, specifically incorporating T2-FLAIR in addition to T1w images, significantly improved the predictive accuracy of PET-determined amyloid status from MRI scans using a deep learning approach. Aβ＝ amyloid-beta; AD＝ Alzheimer's disease; AUC＝ area under the receiver operating characteristic curve; CN＝ cognitively normal; MCI＝ mild cognitive impairment; T1w = T1-wegithed; T2-FLAIR = T2-weighted fluid attenuated inversion recovery; FBP＝¹⁸F-florbetapir; FBB＝¹⁸F-florbetaben; SUVR＝ standard uptake value ratio.

Craniosynostosis, characterized by the premature fusion of cranial sutures, can lead to significant neurological and developmental complications, necessitating early diagnosis and precise treatment. Traditional cranial morphologic assessment has relied on CT scans, which expose infants to ionizing radiation. Recently, 3D stereophotogrammetry has emerged as a noninvasive alternative, but accurately aligning 3D photographs within standardized reference frames, such as the Sella-turcica-Nasion (S-N) frame, remains a challenge. This study proposes a novel method for predicting the Sella turcica (ST) coordinate from 3D cranial surface models using Principal Component Analysis (PCA) combined with a Feedforward Neural Network (FFNN). The accuracy of this method is compared with the conventional Computed Cranial Focal Point (CCFP) method, which has limitations, especially in cases of asymmetric cranial deformations like plagiocephaly. A data set of 153 CT scans, including 68 craniosynostosis subjects, was used to train and test the PCA-FFNN model. The results demonstrate that the PCA-FFNN approach outperforms CCFP, achieving significantly lower deviations in ST coordinate predictions (3.61 vs. 8.38 mm, P<0.001), particularly along the y-axes and z-axes. In addition, mesh realignment within the S-N reference frame showed improved accuracy with the PCA-FFNN method, evidenced by lower mean deviations and reduced dispersion in distance maps. These findings highlight the potential of the PCA-FFNN approach to provide a more reliable, noninvasive solution for cranial assessment, improving craniosynostosis follow-up and enhancing clinical outcomes.

This paper presents the results of a scoping review that examines potentials of Artificial Intelligence (AI) in early diagnosis of Cognitive Decline (CD), which is regarded as a key issue in elderly health. The review encompasses peer-reviewed publications from 2020 to 2025, including scientific journals and conference proceedings. Over 70% of the studies rely on using magnetic resonance imaging (MRI) as the input to the AI models, with a high diagnostic accuracy of 98%. Integration of the relevant clinical data and electroencephalograms (EEG) with deep learning methods enhances diagnostic accuracy in the clinical settings. Recent studies have also explored the use of natural language processing models for detecting CD at its early stages, with an accuracy of 75%, exhibiting a high potential to be used in the appropriate pre-clinical environments.

With the use of artificial intelligence (AI) for image analysis of Magnetic Resonance Imaging (MRI), the lack of training data has become an issue. Realistic synthetic MRI images can serve as a solution and generative models have been proposed. This study investigates the most recent advances on synthetic brain MRI image generation with AI-based generative models. A search has been conducted on the relevant studies published within the last three years, followed by a narrative review on the identified articles. Popular models from the search results have been discussed in this study, including Generative Adversarial Networks (GANs), diffusion models, Variational Autoencoders (VAEs), and transformers.

The Thrombolysis in Cerebral Infarction (TICI) scale is widely used to assess angiographic outcomes of mechanical thrombectomy despite significant variability. Our objective was to create and optimize an artificial intelligence (AI)-based classification model for digital subtraction angiography (DSA) TICI scoring. Using a monocentric DSA dataset of thrombectomies, and a platform for medical image analysis, independent readers labeled each series according to TICI score and marked each thrombus. A convolutional neural network (CNN) classification model was created to classify TICI scores, into 2 groups (TICI 0,1 or 2a versus TICI 2b, 2c or 3) and 3 groups (TICI 0,1 or 2a versus TICI 2b versus TICI 2c or 3). The algorithm was first tested alone, and then thrombi positions were introduced to the algorithm by manual placement firstly, then after using a thrombus detection module. A total of 422 patients were enrolled in the study. 2492 thrombi were annotated on the TICI-labeled series. The model trained on a total of 1609 DSA series. The classification model into two classes had a specificity of 0.97 ±0.01 and a sensibility of 0.86 ±0.01. The 3-class models showed insufficient performance, even when combined with the true thrombi positions, with, respectively, F1 scores for TICI 2b classification of 0.50 and 0.55 ±0.07. The automatic thrombus detection module did not enhance the performance of the 3-class model, with a F1 score for the TICI 2b class measured at 0.50 ±0.07. The AI model provided a reproducible 2-class (TICI 0,1 or 2a versus 2b, 2c or 3) classification according to TICI scale. Its performance in distinguishing three classes (TICI 0,1 or 2a versus 2b versus 2c or 3) remains insufficient for clinical practice. Automatic thrombus detection did not improve the model's performance.

Diagnosis of tumefactive demyelination can be challenging. The diagnosis of indeterminate brain lesions on MRI often requires tissue confirmation via brain biopsy. Noninvasive methods for accurate diagnosis of tumor and nontumor etiologies allows for tailored therapy, optimal tumor control, and a reduced risk of iatrogenic morbidity and mortality. Tumefactive demyelination has imaging features that mimic <i>isocitrate dehydrogenase</i> wild-type glioblastoma (<i>IDH</i>wt GBM). We hypothesized that deep learning applied to postcontrast T1-weighted (T1C) and T2-weighted (T2) MRI can discriminate tumefactive demyelination from <i>IDH</i>wt GBM. Patients with tumefactive demyelination (<i>n</i> = 144) and <i>IDH</i>wt GBM (<i>n</i> = 455) were identified by clinical registries. A 3D DenseNet121 architecture was used to develop models to differentiate tumefactive demyelination and <i>IDH</i>wt GBM by using both T1C and T2 MRI, as well as only T1C and only T2 images. A 3-stage design was used: 1) model development and internal validation via 5-fold cross validation by using a sex-, age-, and MRI technology-matched set of tumefactive demyelination and <i>IDH</i>wt GBM, 2) validation of model specificity on independent <i>IDH</i>wt GBM, and 3) prospective validation on tumefactive demyelination and <i>IDH</i>wt GBM. Stratified area under the receiver operating curves (AUROCs) were used to evaluate model performance stratified by sex, age at diagnosis, MRI scanner strength, and MRI acquisition. The deep learning model developed by using both T1C and T2 images had a prospective validation AUROC of 88% (95% CI: 0.82-0.95). In the prospective validation stage, a model score threshold of 0.28 resulted in 91% sensitivity of correctly classifying tumefactive demyelination and 80% specificity (correctly classifying <i>IDH</i>wt GBM). Stratified AUROCs demonstrated that model performance may be improved if thresholds were chosen stratified by age and MRI acquisition. MRI can provide the basis for applying deep learning models to aid in the differential diagnosis of brain lesions. Further validation is needed to evaluate how well the model generalizes across institutions, patient populations, and technology, and to evaluate optimal thresholds for classification. Next steps also should incorporate additional tumor etiologies such as CNS lymphoma and brain metastases.

The C-arm biplane imaging system, designed for cerebral angiography, detects pathologies like aneurysms using dual rotating detectors for high-precision, real-time vascular imaging. However, accuracy can be affected by source-detector trajectory deviations caused by gravitational artifacts and mechanical instabilities. This study addresses calibration challenges and suggests leveraging interventional devices with radio-opaque markers to optimize C-arm geometry. We propose an online calibration method using image-specific features derived from interventional devices like guidewires and catheters (In the remainder of this paper, the term"catheter" will refer to both catheter and guidewire). The process begins with gantry-recorded data, refined through iterative nonlinear optimization. A machine learning approach detects and segments elongated devices by identifying candidates via thresholding on a weighted sum of curvature, derivative, and high-frequency indicators. An ensemble classifier segments these regions, followed by post-processing to remove false positives, integrating vessel maps, manual correction and identification markers. An interpolation step filling gaps along the catheter. Among the optimized ensemble classifiers, the one trained on the first frames achieved the best performance, with a specificity of 99.43% and precision of 86.41%. The calibration method was evaluated on three clinical datasets and four phantom angiogram pairs, reducing the mean backprojection error from 4.11 ± 2.61 to 0.15 ± 0.01 mm. Additionally, 3D accuracy analysis showed an average root mean square error of 3.47% relative to the true marker distance. This study explores using interventional tools with radio-opaque markers for C-arm self-calibration. The proposed method significantly reduces 2D backprojection error and 3D RMSE, enabling accurate 3D vascular reconstruction.

Diffusion MRI tractography technique enables non-invasive visualization of the white matter pathways in the brain. It plays a crucial role in neuroscience and clinical fields by facilitating the study of brain connectivity and neurological disorders. However, the accuracy of reconstructed tractograms has been a longstanding challenge. Recently, deep learning methods have been applied to improve tractograms for better white matter coverage, but often comes at the expense of generating excessive false-positive connections. This is largely due to their reliance on local information to predict long-range streamlines. To improve the accuracy of streamline propagation predictions, we introduce a novel deep learning framework that integrates image-domain spatial information and anatomical information along tracts, with the former extracted through convolutional layers and the latter modeled via a Transformer-decoder. Additionally, we employ a weighted loss function to address fiber class imbalance encountered during training. We evaluate the proposed method on the simulated ISMRM 2015 Tractography Challenge dataset, achieving a valid streamline rate of 66.2 %, white matter coverage of 63.8 %, and successfully reconstructing 24 out of 25 bundles. Furthermore, on the multi-site Tractoinferno dataset, the proposed method demonstrates its ability to handle various diffusion MRI acquisition schemes, achieving a 5.7 % increase in white matter coverage and a 4.1 % decrease in overreach compared to RNN-based methods.

Recent research has suggested that neuroinflammation may be important in the pathogenesis of neurodegenerative diseases. Free-water diffusion (FWD) has been proposed as a non-invasive neuroimaging-based biomarker for neuroinflammation. Free-water maps were generated using diffusion MRI data in 367 patients from the Ontario Neurodegenerative Disease Research Initiative (108 Alzheimer's Disease/Mild Cognitive Impairment, 42 Frontotemporal Dementia, 37 Amyotrophic Lateral Sclerosis, 123 Parkinson's Disease, and 58 vascular disease-related Cognitive Impairment). The ability of FWD to predict neuroinflammation and neurodegeneration from biofluids was estimated using plasma glial fibrillary-associated protein (GFAP) and neurofilament light chain (NfL), respectively. Recursive Feature Elimination (RFE) performed the strongest out of all feature selection algorithms used and revealed regional specificity for areas that are the most important features for predicting GFAP over NfL concentration. Deep learning models using selected features and demographic information revealed better prediction of GFAP over NfL. Based on feature selection and deep learning methods, FWD was found to be more strongly related to GFAP concentration (measure of astrogliosis) over NfL (measure of neuro-axonal damage), across neurodegenerative disease groups, in terms of predictive performance. Non-invasive markers of neurodegeneration such as MRI structural imaging that can reveal neurodegeneration already exist, while non-invasive markers of neuroinflammation are not available. Our results support the use of FWD as a non-invasive neuroimaging-based biomarker for neuroinflammation.